TULFO ALLEGES BRIBERY AT FDA Senator Raffy Tulfo on Tuesday accused the Food and Drug Administration (FDA) of favoring multinational pharmaceutical companies over small local businesses, alleging that bribery influences product approvals. “Kapag maliit na kumpanya, hindi ninyo inaaprubahan, iniipit ninyo. Pero kapag malaking pharmaceutical company, lalo na multinational, approve kayo nang approve. Why? Because may mga lagay,” Tulfo said. 🎥 Senate of the Philippines | Bilyonaryo News Channel

2.7K views · 34 reactions | Watch this video to learn more about...

FDA approved the 50th biosimilar and released the new Biosimilars Action Plan (BAP). Since FDA’s biosimilars program started, the agency has contributed to the growth of biosimilar adoption and the increasing availability of therapeutic options for patients who face increasing costs and restrictions to access much needed medications. FDA has approved biosimilars to treat a wide range of conditions such as diabetes, skin conditions, bowel disorders, and more. These treatment options can give pati